查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1582708

可摄取智慧药丸的全球市场:产业分析，规模，占有率，成长，趋势，预测(2024年～2031年)

Ingestible Smart Pills Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 147 Pages | 商品交期: 2-5个工作天内

价格
简介目录

本报告提供全球可摄取智慧药丸市场相关调查，提供各成分，各用途，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 摘要整理

第2章 可摄取智慧药丸市场简介

第3章 可摄取智慧药丸市场分析情景

  • 价格分析
  • 市场与预测

第4章 可摄取智慧药丸市场动态

  • 宏观经济要素
  • 促进因素
  • 阻碍因素
  • 机会
  • 趋势
  • 波特的五力分析
  • 价值链分析

第5章 全球可摄取智慧药丸市场分析与预测:各成分

  • 简介
  • 可摄取智慧药丸市场预测:各成分
  • 市场魅力分析:各成分

第6章 全球可摄取智慧药丸市场分析与预测:各用途

  • 简介
  • 可摄取智慧药丸市场预测:各用途
  • 市场魅力分析:各用途

第7章 全球可摄取智慧药丸市场分析与预测:各终端用户

  • 简介
  • 可摄取智慧药丸市场预测:各终端用户
  • 可摄取智慧药丸市场魅力分析:各终端用户

第8章 全球可摄取智慧药丸市场分析与预测:各地区

  • 简介
  • 可摄取智慧药丸市场预测:各地区
  • 可摄取智慧药丸市场魅力分析:各地区

第9章 北美的可摄取智慧药丸市场分析与预测

第10章 南美的可摄取智慧药丸市场分析与预测

第11章 欧洲的可摄取智慧药丸市场分析与预测

第12章 亚太地区的可摄取智慧药丸市场分析与预测

第13章 中东·非洲的可摄取智慧药丸市场分析与预测

第14章 竞争情形

  • 竞争仪表板
  • 企业简介(详细内容- 概要，财务，策略，最近的趋势)
  • 全球市场参与企业
    • BodyCap-Medical
    • Philips Respironics
    • Given Imaging Ltd.
    • Olympus Corporation
    • Proteus Digital Health, Inc.
    • CapsoVision, Inc.
    • Chongqing Jinshan Science and Component(Group)Co., Ltd.
    • Medimetrics
    • IntroMedic Co., Ltd.
    • Check-Cap Ltd.
  • 所使用的前提和缩写
  • 调查手法
简介目录
Product Code: PMRREP14371

Persistence Market Research has recently released a comprehensive report on the global Ingestible Smart Pills market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Ingestible Smart Pills Market Size (2024E): USD 1,200.00 Mn
  • Projected Market Value (2031F): USD 1,852.60 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.4%

Ingestible Smart Pills Market - Report Scope:

Ingestible smart pills represent a significant innovation in healthcare, offering a new approach to diagnosis, patient monitoring, and drug delivery. These tiny devices, ingested orally, are capable of gathering essential data from within the body, transmitting it externally for medical analysis. The primary application areas include gastrointestinal diagnostics, patient monitoring for chronic conditions, and real-time drug effectiveness evaluation. Market growth is primarily driven by the rising demand for minimally invasive diagnostic tools, advancements in sensor technology, and an aging population with increasing healthcare needs.

Market Growth Drivers:

The global Ingestible Smart Pills market is driven by several key factors, including the increasing prevalence of chronic gastrointestinal diseases, which fuels demand for non-invasive diagnostic and monitoring solutions. Advances in sensor technology and miniaturization enable the development of compact, efficient ingestible pills. Rising healthcare awareness and the emphasis on preventive care, along with the growth of digital health technologies, contribute to the market's expansion. The healthcare industry's shift towards personalized medicine also supports the adoption of smart pills, as these devices offer precise, patient-specific data that can guide treatment decisions.

Market Restraints:

Despite promising growth, the Ingestible Smart Pills market faces challenges such as high development and manufacturing costs, stringent regulatory requirements, and limited consumer awareness in emerging regions. The need for specialized facilities and technical expertise to manufacture these devices adds to the overall cost, potentially limiting accessibility. Furthermore, regulatory agencies demand rigorous testing for safety and efficacy, which can delay product launches and increase compliance costs. Privacy concerns surrounding patient data collected by ingestible pills may also hinder adoption, especially in regions with stringent data protection laws.

Market Opportunities:

The Ingestible Smart Pills market presents substantial opportunities with expanding applications across healthcare sectors. There is significant growth potential in new areas like personalized drug delivery and in-patient monitoring for cardiovascular and respiratory conditions. Collaborations between technology firms and healthcare providers could lead to novel solutions that further enhance patient outcomes. Additionally, advances in AI and machine learning could facilitate the development of more sophisticated analysis systems for data collected by ingestible pills, providing deeper insights and enabling predictive diagnostics. Emerging markets with growing healthcare infrastructure also present opportunities for expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Ingestible Smart Pills market globally?
  • Which application areas are leading in the adoption of ingestible smart pill technology?
  • How are advancements in sensor technology shaping the competitive landscape of the Ingestible Smart Pills market?
  • Who are the key players in the Ingestible Smart Pills market, and what strategies are they using to maintain competitiveness?
  • What are the emerging trends and future prospects in the global Ingestible Smart Pills market?

Competitive Intelligence and Business Strategy:

Key players in the global Ingestible Smart Pills market, including Proteus Digital Health, CapsoVision, and Medtronic, are focused on innovation, research, and strategic partnerships to maintain a competitive edge. Companies are investing in R&D to enhance the functionality and accessibility of smart pills, targeting improvements in battery life, data transmission capabilities, and patient comfort. Collaborations with healthcare providers, research institutions, and pharmaceutical companies enable them to extend their market reach and develop targeted solutions. Prioritizing compliance with regulatory standards and data security practices is crucial for fostering consumer trust and encouraging widespread adoption of smart pill technology.

Key Companies Profiled:

  • BodyCap-Medical
  • Philips Respironics
  • Given Imaging Ltd.
  • Olympus Corporation
  • Proteus Digital Health, Inc.
  • CapsoVision, Inc.
  • Chongqing Jinshan Science and Component (Group) Co., Ltd.
  • Medimetrics
  • IntroMedic Co., Ltd.
  • Check-Cap Ltd.
  • Others

Ingestible Smart Pills Industry Segmentation:

By Component

  • Smart Pills
  • Workstation

By Application

  • Imaging
  • Monitoring

By End User

  • Hospitals
  • Clinics
  • Research Institutes
  • Home Healthcare

By Region

  • North America
  • Europe
  • Latin America
  • APAC
  • MEA

Table of Contents

1. Executive Summary

2. Ingestible Smart Pills Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Key Industry Developments

3. Ingestible Smart Pills Market Analysis Scenario

  • 3.1. Pricing Analysis
    • 3.1.1. Pricing Assumptions
    • 3.1.2. Price Projections Per Region
  • 3.2. Market Size (US$ Mn) and Forecast
    • 3.2.1. Market Size and Y-o-Y Growth
    • 3.2.2. Absolute $ Opportunity

4. Ingestible Smart Pills Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
  • 4.3. Restraints
  • 4.4. Opportunities
  • 4.5. Trends
  • 4.6. Porters Five Forces Analysis
  • 4.7. Value Chain Analysis

5. Global Ingestible Smart Pills Market Analysis and Forecast, By Component

  • 5.1. Introduction
    • 5.1.1. Basis Point Share (BPS) Analysis By Component
    • 5.1.2. Y-o-Y Growth Projections By Component
  • 5.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 5.2.1. Smart Pills
      • 5.2.1.1. Patient Monitoring
      • 5.2.1.2. Capsule Endoscopy
        • 5.2.1.2.1. Small Bowel Endoscopy
        • 5.2.1.2.2. Esophagus Endoscopy
        • 5.2.1.2.3. Colon Endoscopy
    • 5.2.2. Workstation
  • 5.3. Market Attractiveness Analysis By Component

6. Global Ingestible Smart Pills Market Analysis and Forecast, By Application

  • 6.1. Introduction
    • 6.1.1. Basis Point Share (BPS) Analysis By Application
    • 6.1.2. Y-o-Y Growth Projections By Application
  • 6.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 6.2.1. Imaging
    • 6.2.2. Monitoring
  • 6.3. Market Attractiveness Analysis By Application

7. Global Ingestible Smart Pills Market Analysis and Forecast, By End User

  • 7.1. Introduction
    • 7.1.1. Basis Point Share (BPS) Analysis By End User
    • 7.1.2. Y-o-Y Growth Projections By End User
  • 7.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 7.2.1. Hospitals
    • 7.2.2. Clinics
    • 7.2.3. Research Institutes
    • 7.2.4. Home Healthcare
  • 7.3. Ingestible Smart Pills Market Attractiveness Analysis By End User

8. Global Ingestible Smart Pills Market Analysis and Forecast, By Region

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Region
    • 8.1.2. Y-o-Y Growth Projections By Region
  • 8.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Region
    • 8.2.1. North America
    • 8.2.2. Latin America
    • 8.2.3. Europe
    • 8.2.4. Asia Pacific
    • 8.2.5. Middle East and Africa
  • 8.3. Ingestible Smart Pills Market Attractiveness Analysis By Region

9. North America Ingestible Smart Pills Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
    • 9.1.3. Key Regulations
  • 9.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 9.3.1. Smart Pills
      • 9.3.1.1. Patient Monitoring
      • 9.3.1.2. Capsule Endoscopy
        • 9.3.1.2.1. Small Bowel Endoscopy
        • 9.3.1.2.2. Esophagus Endoscopy
        • 9.3.1.2.3. Colon Endoscopy
    • 9.3.2. Workstation
  • 9.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 9.4.1. Imaging
    • 9.4.2. Monitoring
  • 9.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 9.5.1. Hospitals
    • 9.5.2. Clinics
    • 9.5.3. Research Institutes
    • 9.5.4. Home Healthcare
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Country
    • 9.6.2. By Component
    • 9.6.3. By Application
    • 9.6.4. By End User
  • 9.7. Prominent Trends
  • 9.8. Drivers and Restraints: Impact Analysis

10. Latin America Ingestible Smart Pills Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
    • 10.1.3. Key Regulations
  • 10.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 10.3.1. Smart Pills
      • 10.3.1.1. Patient Monitoring
      • 10.3.1.2. Capsule Endoscopy
        • 10.3.1.2.1. Small Bowel Endoscopy
        • 10.3.1.2.2. Esophagus Endoscopy
        • 10.3.1.2.3. Colon Endoscopy
    • 10.3.2. Workstation
  • 10.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 10.4.1. Imaging
    • 10.4.2. Monitoring
  • 10.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 10.5.1. Hospitals
    • 10.5.2. Clinics
    • 10.5.3. Research Institutes
    • 10.5.4. Home Healthcare
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Country
    • 10.6.2. By Component
    • 10.6.3. By Application
    • 10.6.4. By End User
  • 10.7. Prominent Trends
  • 10.8. Drivers and Restraints: Impact Analysis

11. Europe Ingestible Smart Pills Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country / Region
    • 11.1.2. Y-o-Y Growth Projections By Country
    • 11.1.3. Key Regulations
  • 11.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country/Region
    • 11.2.1. Germany
    • 11.2.2. France
    • 11.2.3. Italy
    • 11.2.4. Spain
    • 11.2.5. U.K.
    • 11.2.6. Russia
    • 11.2.7. Rest of Western Europe
  • 11.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 11.3.1. Smart Pills
      • 11.3.1.1. Patient Monitoring
      • 11.3.1.2. Capsule Endoscopy
        • 11.3.1.2.1. Small Bowel Endoscopy
        • 11.3.1.2.2. Esophagus Endoscopy
        • 11.3.1.2.3. Colon Endoscopy
    • 11.3.2. Workstation
  • 11.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 11.4.1. Imaging
    • 11.4.2. Monitoring
  • 11.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 11.5.1. Hospitals
    • 11.5.2. Clinics
    • 11.5.3. Research Institutes
    • 11.5.4. Home Healthcare
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Country
    • 11.6.2. By Component
    • 11.6.3. By Application
    • 11.6.4. By End User
  • 11.7. Prominent Trends
  • 11.8. Drivers and Restraints: Impact Analysis

12. Asia Pacific Ingestible Smart Pills Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
    • 12.1.3. Key Regulations
  • 12.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
    • 12.2.1. India
    • 12.2.2. China
    • 12.2.3. Australia and New Zealand
    • 12.2.4. ASEAN
    • 12.2.5. Rest of APEJ
  • 12.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 12.3.1. Smart Pills
      • 12.3.1.1. Patient Monitoring
      • 12.3.1.2. Capsule Endoscopy
        • 12.3.1.2.1. Small Bowel Endoscopy
        • 12.3.1.2.2. Esophagus Endoscopy
        • 12.3.1.2.3. Colon Endoscopy
    • 12.3.2. Workstation
  • 12.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 12.4.1. Imaging
    • 12.4.2. Monitoring
  • 12.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 12.5.1. Hospitals
    • 12.5.2. Clinics
    • 12.5.3. Research Institutes
    • 12.5.4. Home Healthcare
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Country
    • 12.6.2. By Component
    • 12.6.3. By Application
    • 12.6.4. By End User
  • 12.7. Prominent Trends
  • 12.8. Drivers and Restraints: Impact Analysis

13. Middle East & Africa (MEA) Ingestible Smart Pills Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Basis Point Share (BPS) Analysis By Country
    • 13.1.2. Y-o-Y Growth Projections By Country
    • 13.1.3. Key Regulations
  • 13.2. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Country
    • 13.2.1. GCC Countries
    • 13.2.2. South Africa
    • 13.2.3. Rest of MEA
  • 13.3. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Component
    • 13.3.1. Smart Pills
      • 13.3.1.1. Patient Monitoring
      • 13.3.1.2. Capsule Endoscopy
        • 13.3.1.2.1. Small Bowel Endoscopy
        • 13.3.1.2.2. Esophagus Endoscopy
        • 13.3.1.2.3. Colon Endoscopy
    • 13.3.2. Workstation
  • 13.4. Ingestible Smart Pills Market Size (US$ Mn) Forecast By Application
    • 13.4.1. Imaging
    • 13.4.2. Monitoring
  • 13.5. Ingestible Smart Pills Market Size (US$ Mn) Forecast By End User
    • 13.5.1. Hospitals
    • 13.5.2. Clinics
    • 13.5.3. Research Institutes
    • 13.5.4. Home Healthcare
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Country
    • 13.6.2. By Component
    • 13.6.3. By Application
    • 13.6.4. By End User
  • 13.7. Prominent Trends
  • 13.8. Drivers and Restraints: Impact Analysis

14. Competition Landscape

  • 14.1. Competition Dashboard
  • 14.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 14.3. Global Players
    • 14.3.1. BodyCap-Medical
    • 14.3.2. Philips Respironics
    • 14.3.3. Given Imaging Ltd.
    • 14.3.4. Olympus Corporation
    • 14.3.5. Proteus Digital Health, Inc.
    • 14.3.6. CapsoVision, Inc.
    • 14.3.7. Chongqing Jinshan Science and Component (Group) Co., Ltd.
    • 14.3.8. Medimetrics
    • 14.3.9. IntroMedic Co., Ltd.
    • 14.3.10. Check-Cap Ltd.
  • 14.4. Assumptions and Acronyms Used
  • 14.5. Research Methodology